The Business Research Company’s 2026 market reports feature advanced enhancements such as market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, delivering more actionable and strategically valuable research.
What Is The Estimated Growth In Market Size Of The Celiac Disease Treatment Market During 2026–2030?
The celiac disease treatment market has witnessed substantial growth in recent years. Its value is projected to increase from $0.66 billion in 2025 to $0.72 billion in 2026, at a compound annual growth rate (CAGR) of 9.3%. The historic growth in this market can be attributed to various factors, including limited pharmacological treatment options, a strong reliance on gluten-free diet management, rising diagnosis rates, increased awareness of autoimmune disorders, and the growing availability of diagnostic testing.
The celiac disease treatment market size is anticipated to undergo significant expansion in the coming years. It is forecast to reach $1.03 billion in 2030, exhibiting a compound annual growth rate (CAGR) of 9.2%. This projected growth is driven by the emergence of non-dietary therapeutic solutions, the broadening of enzyme and immunotherapy development pipelines, the increasing worldwide incidence of celiac disease, enhanced diagnostic accuracy, and increased financial investment in healthcare for chronic autoimmune conditions. Notable trends for the forecast period include the increasing acceptance of gluten-free dietary management, advancements in enzyme-based therapies, a heightened focus on early detection and screening, the expansion of nutritional supplement-based treatments, and greater patient understanding and education about the disease.
Download A Free Sample Report For Comprehensive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
Which Major Factors Are Contributing To The Development Of The Celiac Disease Treatment Market?
The increasing occurrence of diabetes is projected to fuel the expansion of the celiac disease treatment market in the future. Diabetes, a chronic health condition, involves the body’s inability to properly manage blood sugar or glucose levels. The growing incidence of diabetes stems from common dietary management requirements, given that both diabetes and celiac disease necessitate precise food intake regulation to control blood sugar levels and avoid complications. Celiac disease treatment assists in managing diabetes by encouraging a gluten-free diet, which contributes to better digestive health and nutrient absorption. This approach helps achieve superior blood sugar regulation and lessens complications for people dealing with both ailments. As an illustration, in June 2024, data from the National Health Service, a UK-based government department, indicated that approximately 3,615,330 individuals registered with a general practitioner (GP) received a diagnosis of non-diabetic hyperglycemia or pre-diabetes in 2023. This represented an 18% rise from 3,065,825 cases recorded in 2022. Consequently, the escalating prevalence of diabetes is propelling the development of the celiac disease treatment market.
Which Segment Groups Define The Celiac Disease Treatment Market Landscape?
The celiac disease treatment market covered in this report is segmented –
1) By Treatment Type: Vitamins And Minerals, Gluten Degrading Enzymes, Symptomatic Treatment, Other Treatments
2) By Diagnosis: Serological Tests, Genetic Testing, Biopsy
3) By Distribution Channel: Hospitals, Research Centres, Clinics, Other Distribution Channels
Subsegments:
1) By Vitamins and Minerals: Iron Supplements, Calcium Supplements, Vitamin D, Vitamin B12, Multivitamins
2) By Gluten Degrading Enzymes: Endopeptidases, Exopeptidases, Combination Enzyme Formulations
3) By Symptomatic Treatment: Antidiarrheal Medications, Antidepressants, Anti-inflammatory Drugs, Immunosuppressive Agents
4) By Other Treatments: Probiotics, Immunotherapy, Experimental Therapies
What Trends Are Influencing The Celiac Disease Treatment Market Outlook?
Leading companies operating in the celiac disease treatment market are focusing on creating oral therapies, including small molecule therapies. These aim to provide precise relief by inhibiting immune reactions to gluten, improving patient compliance, and offering alternatives to rigorous gluten-free diets. Small molecule therapies are tiny medications designed to readily enter cells to target and treat proteins or enzymes that cause disease. For instance, in February 2025, Immunic Inc., a US-based biotechnology company, launched IMU-856. IMU-856 is a small molecule that works by increasing endogenous glucagon-like peptide-1 (GLP-1) levels, which helps enhance intestinal barrier function in celiac disease patients. It also improves nutrient absorption and alleviates symptoms without suppressing immune activity.
Who Are The Major Companies Operating In The Celiac Disease Treatment Market?
Major companies operating in the celiac disease treatment market are Pfizer Inc., Johnson And Johnson, F. Hoffmann-La Roche Ltd., Merck And Co. Inc., Sanofi S.A., Novartis AG, Takeda Pharmaceuticals Company Ltd., Amgen Inc., General Mills Inc., Viatris Inc., Teva Pharmaceutical Inc., Nestlé Health Science, Hikma Pharmaceuticals PLC, Amneal Pharmaceuticals LLC, Zydus Pharmaceuticals Inc., Glenmark Pharmaceuticals Company Ltd., West-Ward Pharmaceuticals Company Ltd, Innovate Biopharmaceutical, Acto Biosciences, ImmunogenX
Access The Complete Celiac Disease Treatment Market Report:
https://www.thebusinessresearchcompany.com/report/celiac-disease-treatment-global-market-report
Which Region Leads The Celiac Disease Treatment Market By Size?
North America was the largest region in the celiac disease treatment market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the celiac disease treatment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Access Celiac Disease Treatment Market Report for Deeper Competitive Insights
https://www.thebusinessresearchcompany.com/sample.aspx?id=24186&type=smp
Browse Through More Reports Similar to the Global Celiac Disease Treatment Market 2026, By The Business Research Company
Constipation Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/constipation-treatment-global-market-report
Inflammatory Bowel Disease Treatment Market Report 2026
Crohns Disease Treatment Market Report 2026
https://www.thebusinessresearchcompany.com/report/crohns-disease-treatment-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model